IMW 2019 | Lenalidomide treatment of POEMS syndrome

Arnaud Jaccard

Arnaud Jaccard, MD, PhD, University Hospital Limoges Dupuytren, Limoges, France, elaborates on his study which investigated the efficacy and safety of lenalidomide when treating POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasmaproliferative disorder & Skin changes) syndrome and provides an overview of the initial results. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video